10 completed, 2 recruiting, 1 terminated. 13 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 10, Recruiting 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Risk-Taking: new trials by email Literature Review of Risk-Taking trials Research Report on Risk-Taking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention Luci Coach-Assisted Intervention - Risk Behavior, Cognitive Decline | Phase 3 | Completed | LuciLab | 368 | 2025-03-13 | 2026-11-02 |
| NAlmefene Versus Placebo in Addition to Treatment as Usual on Craving in Behavioural Addictions Nalmefene, Placebo - Behavioural Addiction | Phase 3 | Recruiting | Nantes University Hospital | 266 | 2023-03-31 | 2025-02-12 |
| Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP) Experimental: doxycycline, Bexsero® vaccine - Unsafe Sex, Risk-Taking | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 556 | 2021-01-19 | 2026-04-06 |
| Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation Transcranial Magnetic stimulation - Gambling Disorder | Phase 3 | Recruiting | CNS Onlus | 40 | 2018-05-20 | 2018-09-13 |
| The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder Transcranial direct current stimulation - Gambling Disorder | Phase 3 | Completed | Istanbul University | 20 | 2017-03-29 | 2018-03-26 |
| Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling olanzapine, sugar pill - Pathological Gambling | Phase 3 | Completed | Lindner Center of HOPE | 42 | 2007-02-01 | 2011-12-13 |
| Topiramate in the Treatment of Pathological Gambling Topiramate, Placebo - Pathological Gambling | Phase 3 | Terminated | Icahn School of Medicine at Mount Sinai | 42 | 2005-10-01 | 2019-07-02 |
| Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling nalmefene HCl, Placebo - Pathological Gambling | Phase 2 / Phase 3 | Completed | Somaxon Pharmaceuticals | 233 | 2005-08-01 | 2008-05-19 |
| Minimal and Brief Treatments for Pathological Gamblers Self-help treatment - Pathological Gambling | Phase 3 | Completed | University of Calgary | 312 | 2003-07-01 | 2009-02-16 |
| Drug Treatment for Pathologic Gambling Disorder Naltrexone, Placebo - Gambling | Phase 3 | Completed | University of Chicago | 83 | 2002-12-01 | 2023-02-23 |
| Reducing HIV & Domestic Violence Risk in Women Offenders Motivational interviewing to reduce risk for HIV and DV - HIV Infections, Domestic Violence | Phase 3 | Completed | Multnomah County Health Department | 530 | 2000-09-01 | 2006-02-28 |
| A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts Peer HIV Education Program - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2610 | 2009-10-30 | |
| HIV Prevention Counseling for Men Who Have Sex With Men Behavioral intervention, Risk-reduction counseling - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 4350 | 2008-09-09 |
Gambling (8) · HIV Infections (3) · Cognitive Dysfunction (1) · Compulsive Sexual Behavior Disorder (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Food Addiction (1) · Health Education (1) · Homosexuality, Male (1) · Sexually Transmitted Diseases (1) · Substance Abuse, Intravenous (1) · Substance-Related Disorders (1) · Unsafe Sex (1)
Behavior (13) · Mental Disorders (10) · Disruptive, Impulse Control, and Conduct Disorders (7) · Blood-Borne Infections (3) · Communicable Diseases (3) · Genital Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Infections (3) · Lentivirus Infections (3) · RNA Virus Infections (3) · Retroviridae Infections (3) · Sexually Transmitted Diseases, Viral (3) · Urogenital Diseases (3)
nalmefene (2) · Behavior Therapy (1) · Bibliotherapy (1) · Motivational Interviewing (1) · Naltrexone (1) · Olanzapine (1) · Seroconversion (1) · Sugars (1) · Topiramate (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · ANRS, Emerging Infectious Diseases (1) · CNS Onlus (1) · Icahn School of Medicine at Mount Sinai (1) · Istanbul University (1) · Lindner Center of HOPE (1) · LuciLab (1) · Multnomah County Health Department (1) · Nantes University Hospital (1) · Somaxon Pharmaceuticals (1) · University of Calgary (1) · University of Chicago (1)
United States (6) · Canada (2) · France (2) · Italy (1) · Thailand (1) · Turkey (Türkiye) (1)
Ahmet Z Soyata (1) · Carl Latkin, PhD (1) · Chesney M, Coates T (1) · David C Hodgins, PhD. (1) · Eric Hollander, MD (1) · Koblin B (1) · Michael J. Stark, Ph.D. (1) · Philip Jochelson, MD (1) · Suck Won Kim, M.D. (1) · Susan L McElroy, MD (1)
PMID 15234855, PMID 18251624, PMID 21486110, PMID 23362861, PMID 30367243, PMID 37932493, PMID 38797183, PMID 42004899
2019 (1), R21MH065920 (1)